A federal judge handed down a decision this week in a lawsuit involving the 340B prescription drug discount program as hospitals, physicians, and drug manufacturers continue to battle over how the ...

A machine learning model for prediction of preeclampsia risk using routinely collected data was feasible among pregnancies in ...

Morning light resets the rhythm. By evening, levels of a hormone called melatonin begin to surge, triggering drowsiness. Too much light in the evening -- that extra hour from daylight saving time -- ...

The smart algorithm successfully targeted pulmonary capillary wedge pressure (PCWP) 8-12 mmHg during rest/exercise and PCWP ...

A promising combination for multiple myeloma received FDA approval as a second-line therapy. The approval of teclistamab (Tecvayli) plus daratumumab hyaluronidase (Darzalex Faspro) stipulates use in ...

The loss of staff means the NIH has "lost so much of that institutional knowledge and leadership, which is not something that ...

As expiration dates for key patents approach, the blockbuster cancer drug pembrolizumab (Keytruda) reigned as the biggest pharma moneymaker one more time, edging out the diabetes/weight-loss drug ...

Health Secretary Robert F. Kennedy Jr. plans to loosen restrictions on some peptides that the FDA previously prohibited ...

Marc Ernstoff, MD, who has pioneered immunotherapy research and treatments for cancer patients, said his work as a federal ...